Co-administration phenoxodiol with doxorubicin...

Molecular Oncology 2012 / 08 Vol. 6; Iss. 4

Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro

Yao, Chen, Wu, Sujia, Li, Dong, Ding, Huimin, Wang, Zuyu, Yang, Yongjiang, Yan, Shichang, Gu, Zhangping
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Language:
english
Journal:
Molecular Oncology
DOI:
10.1016/j.molonc.2012.04.002
Date:
August, 2012
File:
PDF, 1.27 MB
english, 2012
Conversion to is in progress
Conversion to is failed